Probability of exposure to the wild measles virus in adult population - Estimation from seroepidemiology and historical data.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
07 Mar 2024
Historique:
received: 09 08 2023
revised: 30 01 2024
accepted: 01 02 2024
medline: 18 3 2024
pubmed: 12 2 2024
entrez: 11 2 2024
Statut: ppublish

Résumé

Vaccination against measles is one of the most effective public health interventions which has saved millions of lives and interrupted circulation of the natural virus in the population. However, it is widely accepted that the immunity after vaccination can wane, especially in those who have had no contact with the virus. This study aimed to classify the particular birth cohorts of adults with regard to their exposure to the wild measles virus in the population with a long history of mandatory vaccination. We introduced two methods. In the first, we estimated the probability of exposure to the wild virus through an analysis of antibody levels from the Immunologic Survey performed in the Slovak Republic in 2018, while the second was based on historical epidemiological data. Both methods resulted in similar estimations. Cohorts born in Slovakia before 1964 can be considered to be cohorts in which most people were exposed to the wild measles virus. Cohorts born after 1977 can be designated as cohorts that most likely did not come into the contact with the wild virus. Cohorts born between 1965 and 1976 are composed of a mixture, with a decreasing proportion of people exposed to the wild virus with increasing year of birth. The proposed methods can help identify potential immunity gaps in the adult population. They can be applied in other countries with high measles vaccination coverage to estimate the probability of exposure to the wild measles virus in particular birth cohorts.

Identifiants

pubmed: 38342718
pii: S0264-410X(24)00149-X
doi: 10.1016/j.vaccine.2024.02.005
pii:
doi:

Substances chimiques

Measles Vaccine 0
Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1648-1655

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jana Zibolenová (J)

Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 11149/4B, 036 01 Martin, Slovakia.

Eva Malobická (E)

Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 11149/4B, 036 01 Martin, Slovakia.

Romana Ulbrichtová (R)

Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 11149/4B, 036 01 Martin, Slovakia.

Martin Novák (M)

Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 11149/4B, 036 01 Martin, Slovakia. Electronic address: martin.novak@jfmed.uniba.sk.

Zuzana Chladná (Z)

Department of Applied Mathematics and Statistics, Faculty of Mathematics, Physics and Informatics, Comenius University in Bratislava, Mlynská dolina F1, 842 48 Bratislava, Slovakia.

Iveta Waczulíková (I)

Department of Nuclear Physics and Biophysics, Faculty of Mathematics, Physics and Informatics, Comenius University in Bratislava, Mlynská dolina F1, 842 48 Bratislava, Slovakia.

Slávka Litvová (S)

Faculty of Healthcare, Alexander Dubcek University of Trencin, Trencin, Slovakia.

Ján Mikas (J)

Public Health Authority of the Slovak Republic, Trnavská cesta 52, 826 45 Bratislava, Slovakia.

Adriana Mečochová (A)

Public Health Authority of the Slovak Republic, Trnavská cesta 52, 826 45 Bratislava, Slovakia.

Henrieta Hudečková (H)

Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá Hora 11149/4B, 036 01 Martin, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH